Global News Aggregator
This year’s tumble in stocks has led many on Wall Street to look at a previously underappreciated part of the market: value. Value stocks are those names that typically trade…
Like many borrowers, Halid Hamade, 28, is poised to benefit — at least somewhat — from student loan forgiveness. After President Joe Biden announced he will forgive $10,000 in federal…
It’s a good time for investors to stock up on shares of Omnicell as the pharmacy industry turns toward automation, Bank of America says. Analyst Allen Lutz initiated coverage of…
They’re all vying for a slice of the more than $4 trillion that Americans spend each year on their health. Source link: https://www.cnbc.com/2022/09/09/how-big-tech-is-muscling-in-on-health-care-we-rank-the-strategies-of-our-4-core-holdings.html
Morgan Stanley names Club holding Amazon top pick in U.S. internet. Source link: https://www.cnbc.com/2022/09/09/what-the-club-is-watching-friday-amazon-a-top-internet-pick-honeywell-a-beneficiary-of-biden-spending.html
Morgan Stanley says investors looking for a hideout in this volatile market should consider putting their money in this lesser known biotechnology stock. Analyst Andrew Galler initiated coverage of Halozyme…
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. We made two trades: AMD,…
In this topsy turvy market, some investors are looking to find solid value stocks. In fact, Goldman Sachs believes the time is right to do just that. In a note…
Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology company, Deutsche Bank said. Analyst Emmanuel Papadakis upgraded shares of the Covid-19 vaccine maker…
Investors are bracing for more volatility ahead, as they navigate what has traditionally been a “seasonally weak” period for stocks . Major U.S. averages closed out their third negative week…